ANAVEX Strongly focused
      on increasing value
HOME  |  ABOUT US  |  PIPELINE  |  R & D  |  PUBLICATIONS  |  PARTNERING  |  INVESTORS  |  CONTACT

Stock Quote
Share Information
Press Releases
SEC Filings
Code of Conduct
Investor Kit
Biopharma Industry
Media
 
Media

Industry Press
July/August 2010, page 18
PharmaVOICE Magazine
The PharmaVOICE 100
Dr. Cameron Durrant: Grounded in Excellence
 Click here to read article

March 31, 2010
Applied Clinical Trials Blog
Chasing After Amyloid
 Click here to read article


Media/Experts Directory
July 23, 2010
Sources (Media Directory)
Sources welcomes Dr. Cameron Durrant, MD, MBA, Alzheimer’s disease and
Pharmaceuticals/Biotech Expert

 Click here to read Sources’ announcement
 Click here to read Dr. Durrant’s profile


Radio Interview

March 26, 2010
Business @ Night on CFRA AM News Talk Radio (Ottawa, Ontario)
In a two-part interview, Business @ Night Host Greg Hebert speaks with Dr. Cameron Durrant, Executive Chairman of Anavex Life Sciences, about the company’s upcoming clinical trials and its compelling drug candidate for the treatment and modification of Alzheimer’s disease.

Listen to:
 Part 1 of Dr. Durrant’s interview (click here)
 Part 2 of Dr. Durrant’s interview (click here)

© 2007-2010 Anavex Life Sciences Corp. - All Rights Reserved.